Sofinnova Investments’s Medtronic MDT Stock Holding History

Sofinnova Investments’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-562,992	Closed	-$50.6M	–	74
2025 Q1	$50.6M	Buy	+562,992	New	+$50.4M	3.3%	7

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sofinnova Investments's MDT Position: Q2 2025 in Review

Sofinnova Investments sold out of Medtronic (MDT) in Q2 2025, closing a stake of 562,992 shares — an estimated $50.6M sold.

Sofinnova Investments first reported a position in MDT in Q1 2025 and held it in 1 quarter. The position peaked at $50.6M in Q1 2025. 2,139 funds tracked by Wall St. Rank hold MDT as of Q2 2025.

Sofinnova Investments reported no remaining Medtronic position as of Q2 2025 after selling out during the quarter.
Sofinnova Investments sold 562,992 Medtronic shares in Q2 2025, an estimated $50.6M.
Sofinnova Investments first reported a position in Medtronic in Q1 2025 and held it in 1 quarter.
Sofinnova Investments's Medtronic position peaked at $50.6M in Q1 2025.
2,139 funds tracked by Wall St. Rank held Medtronic as of Q2 2025.

Based on Sofinnova Investments's 13F filing for Q2 2025, filed 14 Aug 2025.